Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome
Open Access
- 13 February 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 7 (1), srep42316
- https://doi.org/10.1038/srep42316
Abstract
Multicentric Castleman disease (MCD) is a heterogeneous lymphoproliferative disorder. It is characterized by inflammatory symptoms, and interleukin (IL)-6 contributes to the disease pathogenesis. Human herpesvirus 8 (HHV-8) often drives hypercytokinemia in MCD, although the etiology of HHV-8-negative MCD is idiopathic (iMCD). A distinct subtype of iMCD that shares a constellation of clinical features including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been reported as TAFRO-iMCD, however the differences in cytokine profiles between TAFRO-iMCD and iMCD have not been established. We retrospectively compared levels of serum interferon γ-induced protein 10 kDa (IP-10), platelet-derived growth factor (PDGF)-AA, interleukin (IL)-10, and other cytokines between 11 cases of TAFRO-iMCD, 6 cases of plasma cell type iMCD, and 21 healthy controls. During flare-ups, patients with TAFRO-iMCD had significantly higher serum IP-10 and tended to have lower PDGF-AA levels than the other 2 groups. In addition, serum IL-10, IL-23, and vascular endothelial growth factor-A were elevated in both TAFRO-iMCD and iMCD. Elevated serum IP-10 is associated with inflammatory diseases including infectious diseases. There was a strong correlation between high serum IP-10 and the presence of TAFRO-iMCD, suggesting that IP-10 might be involved in the pathogenesis of TAFRO-iMCD.This publication has 36 references indexed in Scilit:
- Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseBlood, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- IL‐6 Triggers IL‐21 production by human CD4+ T cells to drive STAT3‐dependent plasma cell differentiation in B cellsImmunology & Cell Biology, 2012
- CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implicationsCytokine & Growth Factor Reviews, 2011
- Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacitiesBlood, 2009
- Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman diseaseBlood, 2005
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993
- Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.Proceedings of the National Academy of Sciences of the United States of America, 1989
- The biology of platelet-derived growth factorCell, 1986